| Nutritional keys for intestinal barrier modulation S De Santis, E Cavalcanti, M Mastronardi, E Jirillo, M Chieppa Frontiers in immunology 6, 167739, 2015 | 231 | 2015 |
| Combined dietary anthocyanins, flavonols, and stilbenoids alleviate inflammatory bowel disease symptoms in mice A Scarano, E Butelli, S De Santis, E Cavalcanti, L Hill, M De Angelis, ... Frontiers in Nutrition 4, 75, 2018 | 104 | 2018 |
| Role of PD-L1 expression as a biomarker for GEP neuroendocrine neoplasm grading E Cavalcanti, R Armentano, AM Valentini, M Chieppa, ML Caruso Cell death & disease 8 (8), e3004-e3004, 2017 | 99 | 2017 |
| Current insights in renal cell cancer pathology V Mancini, M Battaglia, P Ditonno, S Palazzo, G Lastilla, R Montironi, ... Urologic Oncology: Seminars and Original Investigations 26 (3), 225-238, 2008 | 62 | 2008 |
| Dysfunctional DC subsets in RCC patients: ex vivo correction to yield an effective anti-cancer vaccine M Gigante, A Blasi, A Loverre, V Mancini, M Battaglia, FP Selvaggi, ... Molecular immunology 46 (5), 893-901, 2009 | 57 | 2009 |
| Interferon-alpha (IFN-α)–conditioned DC Preferentially Stimulate Type-1 and Limit Treg-type In Vitro T-cell Responses From RCC Patients M Gigante, M Mandic, AK Wesa, E Cavalcanti, M Dambrosio, V Mancini, ... Journal of immunotherapy 31 (3), 254-262, 2008 | 56 | 2008 |
| Reverse transcriptase inhibitors induce cell differentiation and enhance the immunogenic phenotype in human renal clear‐cell carcinoma M Landriscina, SA Altamura, L Roca, M Gigante, A Piscazzi, E Cavalcanti, ... International journal of cancer 122 (12), 2842-2850, 2008 | 54 | 2008 |
| Administration of reconstituted polyphenol oil bodies efficiently suppresses dendritic cell inflammatory pathways and acute intestinal inflammation E Cavalcanti, E Vadrucci, FR Delvecchio, F Addabbo, S Bettini, R Liou, ... PLoS One 9 (2), e88898, 2014 | 50 | 2014 |
| miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction M Gigante, P Pontrelli, W Herr, M Gigante, M D’Avenia, G Zaza, ... Journal of translational medicine 14, 1-13, 2016 | 49 | 2016 |
| Dendritic cells modulate iron homeostasis and inflammatory abilities following quercetin exposure V Galleggiante, S De Santis, E Cavalcanti, A Scarano, M De Benedictis, ... Current pharmaceutical design 23 (14), 2139-2146, 2017 | 46 | 2017 |
| Secretory leukoprotease inhibitor is required for efficient quercetin-mediated suppression of TNFα secretion S De Santis, D Kunde, G Serino, V Galleggiante, ML Caruso, ... Oncotarget 7 (46), 75800, 2016 | 41 | 2016 |
| Galunisertib modifies the liver fibrotic composition in the Abcb4Ko mouse model S Hammad, E Cavalcanti, J Werle, ML Caruso, A Dropmann, A Ignazzi, ... Archives of toxicology 92, 2297-2309, 2018 | 40 | 2018 |
| TNFα deficiency results in increased IL-1β in an early onset of spontaneous murine colitis S De Santis, D Kunde, V Galleggiante, M Liso, L Scandiffio, G Serino, ... Cell death & disease 8 (8), e2993-e2993, 2017 | 37 | 2017 |
| Polyphenol administration impairs T‐cell proliferation by imprinting a distinct dendritic cell maturational profile FR Delvecchio, E Vadrucci, E Cavalcanti, S De Santis, D Kunde, M Vacca, ... European journal of immunology 45 (9), 2638-2649, 2015 | 36 | 2015 |
| JAK3/STAT5/6 Pathway Alterations Are Associated with Immune Deviation in T Cells in Renal Cell Carcinoma Patients E Cavalcanti, M Gigante, V Mancini, M Battaglia, P Ditonno, ... BioMed Research International 2010, 2010 | 36 | 2010 |
| miR-369-3p modulates inducible nitric oxide synthase and is involved in regulation of chronic inflammatory response V Scalavino, M Liso, E Cavalcanti, I Gigante, A Lippolis, M Mastronardi, ... Scientific Reports 10 (1), 15942, 2020 | 33 | 2020 |
| Quercetin exposure suppresses the inflammatory pathway in intestinal organoids from winnie mice M Dicarlo, G Teti, G Verna, M Liso, E Cavalcanti, A Sila, S Raveenthiraraj, ... International Journal of Molecular Sciences 20 (22), 5771, 2019 | 33 | 2019 |
| JAK3 in clear cell renal cell carcinoma: mutational screening and clinical implications M de Martino, M Gigante, L Cormio, C Prattichizzo, E Cavalcanti, ... Urologic Oncology: Seminars and Original Investigations 31 (6), 930-937, 2013 | 27 | 2013 |
| Interleukin 1β Blockade Reduces Intestinal Inflammation in a Murine Model of Tumor Necrosis Factor–Independent Ulcerative Colitis M Liso, G Verna, E Cavalcanti, S De Santis, R Armentano, A Tafaro, ... Cellular and Molecular Gastroenterology and Hepatology 14 (1), 151-171, 2022 | 24 | 2022 |
| PDGFRα expression as a novel therapeutic marker in well-differentiated neuroendocrine tumors E Cavalcanti, A Ignazzi, F De Michele, ML Caruso Cancer Biology & Therapy 20 (4), 423-430, 2019 | 18 | 2019 |
Marcello ChieppaUniversità del Salento, Dipartimento di Scienze e Tecnologie Biologiche ed Ambientali (DiSTeBA)Verified email at unisalento.it
